A sensing nucleic acid nanopore is provided. The nanopore possesses a geometry and wherein the nanopore defines a central lumen passing therethrough. The geometry of the nanopore is configured to accommodate all or a part of an analyte molecule within, or proximate to, the central lumen so as to optimize obstruction of the central lumen by the analyte molecule. Methods for enhancing binding of an analyte molecule to a membrane-spanning nanopore are provided. Membranes, sensor devices and methods for molecular sensing comprising the sensing nucleic acid nanopores are also provided.

The invention generally relates to methods for quantifying an amount of enzyme molecules. Systems and methods of the invention are provided for measuring an amount of target by forming a plurality of fluid partitions, a subset of which include the target, performing an enzyme-catalyzed reaction in the subset, and detecting the number of partitions in the subset. The amount of target can be determined based on the detected number.

The invention generally relates to methods for quantifying an amount of enzyme molecules. Systems and methods of the invention are provided for measuring an amount of target by forming a plurality of fluid partitions, a subset of which include the target, performing an enzyme-catalyzed reaction in the subset, and detecting the number of partitions in the subset. The amount of target can be determined based on the detected number.

This document provides methods and materials for detecting target nucleic acid. For example, methods and materials for detecting the presence or absence of target nucleic acid, methods and materials for detecting the amount of target nucleic acid present within a sample, kits for detecting the presence or absence of target nucleic acid, kits for detecting the amount of target nucleic acid present within a sample, and methods for making such kits are provided.

This document provides methods and materials for detecting target nucleic acid. For example, methods and materials for detecting the presence or absence of target nucleic acid, methods and materials for detecting the amount of target nucleic acid present within a sample, kits for detecting the presence or absence of target nucleic acid, kits for detecting the amount of target nucleic acid present within a sample, and methods for making such kits are provided.

The present specification discloses methods of detecting a contaminant of interest in a sample, components useful in carrying out these methods, including PCR primers and a detection solution and kits thereof.

The present specification discloses methods of detecting a contaminant of interest in a sample, components useful in carrying out these methods, including PCR primers and a detection solution and kits thereof.

The invention generally relates to capturing, amplifying, and sequencing nucleic acids. In certain embodiments, linked capture probes and multiple binding and extension steps improve specificity over traditional single binding target capture techniques. Methods of seeding sequencing clusters with captured target nucleic acids are also disclosed. Linked adapters may be used to increase adapter ligation selectively or efficiency and yield. Ligation adapters and primers can be linked to various sequence-specific or feature-specific molecules to selectively bind targets for ligation or amplification with universal adapters or primers.

The invention generally relates to capturing, amplifying, and sequencing nucleic acids. In certain embodiments, linked capture probes and multiple binding and extension steps improve specificity over traditional single binding target capture techniques. Methods of seeding sequencing clusters with captured target nucleic acids are also disclosed. Linked adapters may be used to increase adapter ligation selectively or efficiency and yield. Ligation adapters and primers can be linked to various sequence-specific or feature-specific molecules to selectively bind targets for ligation or amplification with universal adapters or primers.

Provided herein are methods that utilize a CRISPR/Cas complex having collateral activity, one or more nucleases, one or more oligonucleotides and a fluorescent reporter. The methods disclosed herein can amplify a fluorescent signal when a target nucleic acid is present in a sample.